Back | Next |
home / stock / novn / novn message board
Subject | By | Source | When |
---|---|---|---|
Been holding this one mick..will wait to see | BDEZ | investorshub | 09/16/2021 1:37:10 AM |
pbs.twimg.com/media/E WCTBUXEAAg7LZ?format=jpg&name=large | mick | investorshub | 09/15/2021 7:50:56 PM |
should be at 30. but finally back at 10 | endlich0 | investorshub | 09/08/2021 9:19:19 PM |
whytestocks: $NOVN News Article - Novan Engages Syneos Health as Commercial Solutions Provider for S | whytestocks | investorshangout | 09/08/2021 5:10:50 PM |
whytestocks: $NOVN News Article - Novan Reports Second Quarter 2021 Financial Results and Provides C | whytestocks | investorshangout | 08/12/2021 5:00:48 PM |
What else is new... | BDEZ | investorshub | 06/21/2021 11:14:21 PM |
DILUTED again! | endlich0 | investorshub | 06/21/2021 5:19:44 PM |
$NOVN hit 20 bucks...did not expect this, nice | BDEZ | investorshub | 06/15/2021 6:32:41 AM |
znewcar1: NOVN 62% v126M c14.68 f15,1M H18.68 S13.8 | znewcar1 | investorshangout | 06/11/2021 8:06:11 PM |
Dipped into the $NOVN cookie jar this morning.....anyone | davidsson10 | investorshub | 06/11/2021 7:08:03 PM |
Sparks have ignited. | gastric | investorshub | 06/11/2021 4:50:47 PM |
Was | akamaii | investorshub | 06/11/2021 4:21:56 PM |
Management are scum bags for doing R/S just | shurtha2000 | investorshub | 06/11/2021 2:35:04 PM |
Excellent FDA phase III clinical results! | crudeoil24 | investorshub | 06/11/2021 2:29:50 PM |
whytestocks: $NOVN News Article - Novan Reports Positive Topline Results from Pivotal Phase 3 Trial | whytestocks | investorshangout | 06/11/2021 2:05:48 PM |
GOINNNNN UP | blackpilled | investorshub | 06/11/2021 1:01:51 PM |
$NOVN $14.70 should go higher only recovering gains | shurtha2000 | investorshub | 06/11/2021 12:53:17 PM |
more strange things are happening right now | endlich0 | investorshub | 05/27/2021 8:14:45 PM |
$8.35 a share according to yesterday's close.... not | Nickwvt | investorshub | 05/26/2021 3:19:45 PM |
Yeah. That was weird. | daleb2130 | investorshub | 05/25/2021 10:09:35 PM |
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...